Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

Share Price is delayed by 15 minutes
Get Live Data
221.00    -1.00 (-0.45%)
Bid:
221.00
Ask:
232.00
Spread: 11.00 (4.977%)
Market Cap: £116.68m
APTD Live PriceLast checked at - London Stock Exchange

Intraday Aptitude Share Chart

Interim Management Statement

28 Apr 2014 07:00

RNS Number : 5910F
Microgen PLC
28 April 2014
 



microgen

www.microgen.com

 

28 April 2014

 

INTERIM MANAGEMENT STATEMENT

 

 

In advance of the Company's Annual General Meeting today, Microgen plc ('Microgen' or 'the Group') provides its Interim Management Statement covering the period from 1 January 2014 to the date of this announcement. Microgen released its final results for year ended 31 December 2013 on 26 February 2014.

 

There have been no significant changes since 1 January 2014 in the trading or financial position of Microgen and its balance sheet remains strong. The Group had cash at 31 March 2014 of £40.6 million (31 December 2013: £40.2 million) and net funds of £22.1 million (31 December 2013: £20.9 million).

 

Investment continues in the Aptitude Software business in order to pursue the developing Big Data opportunity and, as anticipated, the contract with a North American prospect was signed shortly after the release of Microgen's results on 26 February 2014. In addition, the latest version of the Aptitude software is being launched today in line with the timetable set out in last year's Strategic Review. With this release Aptitude customers will have the ability to incorporate Hadoop into Aptitude-based multi-platform Big Data solutions.

 

The Financial Systems business continues to perform satisfactorily and is pursuing the strategy defined in 2013 to focus on the wealth management sector.

 

Microgen is continuously identifying and evaluating businesses and strategic investments which the Board believes may benefit from being operated as an independent business unit under Microgen's stewardship and thereby enhance value for shareholders. The Board will maintain its prudent approach and there can be no certainty that any material acquisition will be completed.

 

Contacts

Martyn Ratcliffe, Executive Chairman 020-7496-8100

Philip Wood, Group Finance Director

 

Lucy Delaney, FTI Consulting 020-3727-1131

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSIAMATMBITBLI
Date   Source Headline
17th Apr 202311:49 amRNSHolding(s) in Company
17th Apr 20238:32 amRNSHolding(s) in Company
29th Mar 20234:36 pmRNSDirector/PDMR Shareholding
29th Mar 20234:35 pmRNSPrice Monitoring Extension
29th Mar 202311:27 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Mar 20237:00 amRNSAudited Results for Year Ended 31 December 2022
13th Feb 20235:20 pmRNSHolding(s) in Company
1st Feb 20234:40 pmRNSSecond Price Monitoring Extn
1st Feb 20234:35 pmRNSPrice Monitoring Extension
26th Jan 20237:00 amRNSHolding(s) in Company
24th Jan 20237:00 amRNSFull Year Trading Update and Directorate Change
12th Jan 20239:51 amRNSNew Directorship Notification
24th Nov 20227:00 amRNSGrant of awards under Performance Share Plan
8th Nov 20227:00 amRNSGrant of awards
21st Oct 20224:41 pmRNSSecond Price Monitoring Extn
21st Oct 20224:36 pmRNSPrice Monitoring Extension
28th Sep 20227:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Jul 20227:00 amRNSInterim Results
18th Jul 20227:00 amRNSNotice of Results
31st May 202211:40 amRNSTotal Voting Rights
26th May 20228:56 amRNSHolding(s) in Company
17th May 20221:57 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20222:10 pmRNSDirector Shareholding
29th Apr 202210:56 amRNSTotal Voting Rights
28th Apr 202212:24 pmRNSResult of AGM and Directorate Change
28th Apr 20227:00 amRNSAGM Statement
12th Apr 202211:50 amRNSBlock Listing Application
11th Apr 20222:30 pmRNSBlock listing Interim Review
4th Apr 20227:00 amRNSGrant of awards under 2020 Deferred Bonus Plan
22nd Mar 20227:00 amRNSDirector/PDMR Shareholding
15th Mar 20227:00 amRNSAudited Preliminary Results
1st Mar 20221:00 pmRNSTotal Voting Rights
1st Feb 202211:05 amRNSTotal Voting Rights
20th Jan 20227:00 amRNSTrading Update and Notice of Results
1st Dec 20217:00 amRNSTotal Voting Rights
8th Nov 20215:05 pmRNSGrant of awards under Performance Share Plan
1st Nov 20214:50 pmRNSTotal Voting Rights
25th Oct 20217:00 amRNSBlock Listing Application
11th Oct 20217:00 amRNSAcquisition of MPP Global Solutions Limited
1st Oct 20217:00 amRNSNon-Executive Directorate and Committee Changes
28th Sep 202111:24 amRNSBlock listing Interim Review
17th Sep 20217:00 amRNSChange of Auditor
28th Jul 20217:00 amRNSInterim Results
16th Jul 20217:00 amRNSNotice of Results
6th Jul 202110:39 amRNSHolding(s) in Company
1st Jul 20217:00 amRNSTotal Voting Rights
15th Jun 20219:57 amRNSDirector Declaration
27th May 20218:20 amRNSDirector Declaration
6th May 20213:36 pmRNSDirector/PDMR Shareholding and Total Voting Rights
5th May 20213:27 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.